← Back to Search

"MyPlan" - Individualized Planned Eating Pattern for Type 1 Diabetes

N/A

Waitlist Available

Led By Elizabeth J Mayer-Davis, PhD

Research Sponsored by University of North Carolina, Chapel Hill

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 22-24

Awards & highlights

Study Summary

This trial is testing an individualized eating strategy to improve glycemic management in youth with type 1 diabetes. Participants will be assessed for acceptability and adherence to the plan, and changes in glycemic levels will be compared to baseline. The goal is to inform the design of a future randomized clinical trial.

Eligible Conditions

Type 1 Diabetes

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 22-24

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 22-24

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 22-24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability Percentage (Guardian)

Acceptability Percentage (Youth)

Adherence to 0-5 Eating Behavior Goals

+6 more

Secondary outcome measures

Change in Hemoglobin A1c Percentage

Trial Design

1Treatment groups

Experimental Treatment

Group I: "MyPlan" - Individualized Planned Eating PatternExperimental Treatment1 Intervention

All youth enrolled in the study will receive the 6-month MyPlan behavioral intervention. Youth and their guardian will be paired with a dietitian to individualize the eating pattern and receive support in setting and refining action plans focused on adhering to the five eating behavior goals that define the eating pattern.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

"MyPlan" - Individualized Planned Eating Pattern

2021

N/A

~60

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH

2,364 Previous Clinical Trials

4,315,350 Total Patients Enrolled

University of CincinnatiOTHER

428 Previous Clinical Trials

634,342 Total Patients Enrolled

University of North Carolina, Chapel HillLead Sponsor

1,510 Previous Clinical Trials

4,193,041 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research still enrolling participants?

"Data hosted by clinicaltrials.gov indicates that recruitment for this trial is ongoing since its inception on December 13th 2021, with the last edit occurring January 13th 2022."

Answered by AI

How many participants are eligible to join this clinical research study?

"Correct. Clinicaltrials.gov has information that demonstrates the feasibility of this trial, which was initially advertised on December 13th 2021, is actively seeking recruits. A total of 50 individuals are needed at 2 clinical sites."

Answered by AI

Does the eligibility for this clinical trial extend to individuals younger than 60 years of age?

"This clinical trial is limited to adolescents aged 12-17 years old. According to the data, there are 218 studies specifically for those below 18 and 924 for seniors above 65."

Answered by AI

Do I meet the criteria to participate in this experiment?

"This clinical trial seeks 50 participants aged between 12-17 years old with a minimum one year history of Type 1 diabetes Mellitus and HbA1c levels in the range 8-11%. Furthermore, guardians must be willing to take part, while English is preferred as the language."

Answered by AI